(Q44543648)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Effects of a subanaesthetic dose of ketamine on emotional and behavioral state in healthy subjects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Micallef J

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Tardieu S

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Gentile S

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Fakra E

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Sambuc R

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Blin O

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909392%20AND%20SRC:MED&resulttype=core&format=json

Neurophysiologie Clinique

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

138-147

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909392%20AND%20SRC:MED&resulttype=core&format=json

Serotonin model of schizophrenia: emerging role of glutamate mechanisms

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Negative v positive schizophrenia. Definition and validation.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

The evolving concept of schizophrenia: from Kraepelin to the present and future

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

A study of emotional processing in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Perception of facial emotion in schizophrenic and right brain-damaged patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Affect recognition in deficit syndrome schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Emotional responding in deficit and non-deficit schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Facial affect and affective prosody recognition in first-episode schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

N-methyl-D-aspartate receptors and information processing: human choice reaction time under a subanaesthetic dose of ketamine

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

An fMRI study of facial emotion processing in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

THE ADDICTION RESEARCH CENTER INVENTORY: STANDARDIZATION OF SCALES WHICH EVALUATE SUBJECTIVE EFFECTS OF MORPHINE, AMPHETAMINE, PENTOBARBITAL, ALCOHOL, LSD-25, PYRAHEXYL AND CHLORPROMAZINE

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Sequential regional cerebral blood flow brain scans using PET with H2(15)O demonstrate ketamine actions in CNS dynamically

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Emotional facial imagery, perception, and expression in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Differential amygdala response during facial recognition in patients with schizophrenia: an fMRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Facial expression of schizophrenic patients and their interaction partners.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Interactive effects of subanesthetic ketamine and haloperidol in healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Neural correlates of response inhibition for behavioral regulation in humans assessed by functional magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Treatment and diagnostic subtype in facial affect recognition in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Noncompetitive excitatory amino acid receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Generality and specificity of emotion-recognition deficit in schizophrenic patients with positive and negative symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

The effects of a sub-anaesthetic dose of ketamine on human selective attention.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Inducing and assessing differentiated emotion-feeling states in the laboratory

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Does ketamine-mediated N-methyl-D-aspartate receptor antagonism cause schizophrenia-like oculomotor abnormalities?

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Emotional processing in schizophrenia: neurobehavioral probes in relation to psychopathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG).

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Ketamine effects on eye movements

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Ketamine--its pharmacology and therapeutic uses.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

Flat affect in schizophrenia does not reflect diminished subjective experience of emotion

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2803%2900028-5

7 January 2021

10.1016/S0987-7053(03)00028-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference